SAR439859 SAR-439859
We provide customized and high-quality Amcenestrant product for your project.
Amcenestrant is an orally available nonsteroidal selective estrogen receptor degrader (SERD). Amcenestrant was developed by Sanofi for the treatment of ER+/HER2- advanced or metastatic breast cancer.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View